triethylenemelamine has been researched along with Malignant Melanoma in 3 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FEIND, CR | 1 |
| HERTER, F | 1 |
| MARKOWITZ, A | 1 |
| JOHNSTON, ID | 1 |
| VIGI, F | 1 |
3 other studies available for triethylenemelamine and Malignant Melanoma
| Article | Year |
|---|---|
IMPROVEMENTS IN ISOLATION HEAD PERFUSION.
Topics: Carcinoma, Squamous Cell; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Child; Chordom | 1963 |
THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Per | 1963 |
[ANTINEOPLASTIC PREPARATIONS USED AS A MEANS OF PROTECTION AGAINST THE FREE ELEMENTS IN THE BLOOD AND CONTAMINATION BY NEOPLASTIC CELLS, IN OPERATIVE INTERVENTIONS].
Topics: Antineoplastic Agents; Carcinoma; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Melano | 1963 |